多omics分析显示CDKN2A突变早期发病的肺状细胞癌,具有"热"的瘤免疫微环境
Ying Zhang1, Pei Yuan1, Bingzhi Wang1
1Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Translational lung cancer research
|March 11, 2026
概括
早期发病的肺状细胞癌 (LUSC) 具有CDKN2A突变,在年轻患者中呈现出具有侵略性但免疫性特征的特征. 这一发现凸显了CDKN2A作为指导早期LUSC免疫治疗的潜在生物标志物.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 早期发病的肺状细胞癌 (LUSC) 是一种罕见的疾病,人们对其了解甚少.
- 它独特的临床病理学,基因组学和瘤免疫微环境 (TIME) 资料需要阐明.
- 这项研究研究了早期LUSC的分子格局和免疫表型.
研究的目的:
- 探索早期LUSC的分子景观.
- 描述早期发病的LUSC的免疫表型.
- 发现早期LUSC的临床特征的基因组关联.
主要方法:
- 对21名以前未接受过治疗的LUSC早期发病患者 (≤40岁) 的回顾性单中心队列研究.
- 使用整体外体序列测序 (WES) 和数字空间分析 (DSP) 进行全面的多omics分析.
- 与癌症基因组图谱 (TCGA) LUSC数据进行比较分析.
主要成果:
- CDKN2A突变的高频率 (47.6%),通常与TP53突变同时发生.
- CDKN2A突变的LUSC表现出侵略性特征 (较高的Ki67,血管入侵) 和"热"的TIME,具有丰富的细胞毒性/耗尽的CD8+T细胞和升高的PD-L1.
- 这种免疫性特征是早期发病的LUSC与一般LUSC种群相比独特的.
结论:
- CDKN2A突变定义了早期发病的LUSC的独特,侵略性和免疫性亚型.
- 发病年龄是LUSC的关键生物变量.
- CDKN2A状态可以作为早期LUSC免疫治疗的生物标志物.
相关概念视频
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
02:21Cancers Originate from Somatic Mutations in a Single Cell
15.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.3K
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
02:39lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K